Epidemiological studies have also supported gene-diet interactions in AD risk, with evidence suggesting that protective effects of omega 3 fatty acid intake may be modulated by APOE genotype and complement-related genes such as CLU and CR1 [376]. This evidence concerns the gene CLU and Alzheimer disease.